CMEA Ventures leads $10M round with four other venture investment groups
Sunnyvale, CA – September 16, 2008 – VasoNova, Inc., the leader in algorithm-based vascular navigation and measurement technology, has raised $10 million dollars in Series B funding in August 2008 from venture investors. The round was led by CMEA Ventures. Other investors included California Technology Partners, Research Corporation Technologies, Aphelion Medical Fund and Arboretum Ventures.
The funds will be used to expand market development and customer acquisition, scale product development, and build the customer support and service infrastructure in preparation for product launch in the US market.
CMEA Capital is a venture capital firm focusing on life sciences, high technology, and energy and materials investments. CMEA Capital was founded in 1989. They invest in both early and late stage science-focused ventures, and leverage a strong network of corporate, investment, and entrepreneurial relationships on behalf of portfolio companies. CMEA has offices in both San Francisco and Menlo Park. For more information, see www.cmea.com.
VasoNova, Inc. has created, developed and commercialized an innovative vascular navigation system. Founded in 2005, VasoNova is the leader in algorithm-based vascular navigation and measurement technology, committed to innovating high quality medical devices to help clinicians address patient needs and improve patient care. VasoNova is located in Sunnyvale, CA. For more information, point your browser to www.vasonova.com.
Please contact your sales representative, VasoNova Customer Service at 650.388.5600 or firstname.lastname@example.org for more information.